Velocity’s research site in Charleston partners with area physicians to conduct diverse clinical trials. Offering multi-therapeutic expertise across numerous internal medicine indications, the site staff has experience in managing vaccine, allergy, pediatric, and neurology trials, among other areas. Acquired by Velocity in 2022, the Charleston location was established in 2021 as an integral part of Meridian Clinical Research.
Located just off of I-526, the site is easily accessible to thousands of patients, including those established with the practice and diverse populations. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Charleston team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.